Home
>
National Drug Code (NDC)
>
FANAPT
FANAPT - 0078-0595-20 - (Iloperidone)
Drug Information of FANAPT
| Product NDC: | 0078-0595 |
| Proprietary Name: | FANAPT |
| Non Proprietary Name: | Iloperidone |
| Active Ingredient(s): | 1 mg/1 & nbsp; Iloperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of FANAPT
| Product NDC: | 0078-0595 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022192 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091001 |
Package Information of FANAPT
| Package NDC: | 0078-0595-20 |
| Package Description: | 60 TABLET in 1 BOTTLE (0078-0595-20) |
NDC Information of FANAPT
| NDC Code | 0078-0595-20 |
| Proprietary Name | FANAPT |
| Package Description | 60 TABLET in 1 BOTTLE (0078-0595-20) |
| Product NDC | 0078-0595 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Iloperidone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20091001 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ILOPERIDONE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
